National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 305012

Case Details

VAERS ID: 305012 (history)  
Form: Version 1.0  
Age: 20.0  
Sex: Female  
Location: California  
Submitted: 2008-02-14
Entered: 2008-02-15
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: Other
Symptoms: Anxiety, Blood aluminium increased, Depression, Mental disorder, Serum serotonin decreased
SMQs:, Dementia (broad), Depression (excl suicide and self injury) (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0802USA01915

Write-up: Information has been received from a medical assistant concerning a female in her early 20''s who on an unspecified date in 2007 the patient received her first dose of GARDASIL injection. Concomitant therapy on the same date also included another vaccine (therapy unspecified). On an unspecified date the patient received her second dose of GARDASIL. The patient had a "nervous breakdown; some kind of anxiety or severe depression". The patient was admitted to the hospital and was found to have decreased serotonin levels and aluminum toxicity. The dates of the hospitalization are not known but the patient was discharged and was started on an antidepressant (therapy unspecified). The patient has not received her third dose yet. At the time of reporting the patient was recovering. Additional information has been requested.

New Search

Link To This Search Result:

Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166